Swing,
I had trouble hearing parts of it too but here's the parts that stuck with me.
It sounds like it will be another couple of months to finish enrollment.
They haven't given up on the bond offering.Al did say something to that effect last February...
"We are continuing to work on several minimally dilutive financings, but in today's world, it seems to take much longer to complete such transactions. We therefore certainly needed to act decisively and quickly to raise capital, not to do so would have been very foolish. We therefore undertook the recent equity offering with net to the company about $81 million. Unfortunately, that financing was quite dilutive, yet it will provide resources for the company while we continue our pursuit of non-dilutive and minimally diluted financing to satisfy our needs to approval and beyond."
They are not planning to launch without a partner.
They prefer to wait until financing is settled and then partner.
Matt also brought up possible deal(s) in the Middle East.
Matt sees Afrezza being used after Metformin is no longer effective.(Metformin is a good drug and cheap.)
